Ignite Creation Date:
2025-12-25 @ 4:29 AM
Ignite Modification Date:
2026-05-12 @ 8:45 AM
Study NCT ID:
NCT01320020
Status:
TERMINATED
Last Update Posted:
2013-07-02
First Post:
2011-03-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Open Label, Dose Escalating Study to Evaluate the Safety and Tolerability of Ascending Intravenous (i.v.) Doses of Catumaxomab in Epithelial Cancer Patients
Sponsor:
Neovii Biotech
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
IV-CAT-ST-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None